JPS58225012A - Composition of drug for stomach and intestines, and for headache, and its preparation - Google Patents
Composition of drug for stomach and intestines, and for headache, and its preparationInfo
- Publication number
- JPS58225012A JPS58225012A JP11034082A JP11034082A JPS58225012A JP S58225012 A JPS58225012 A JP S58225012A JP 11034082 A JP11034082 A JP 11034082A JP 11034082 A JP11034082 A JP 11034082A JP S58225012 A JPS58225012 A JP S58225012A
- Authority
- JP
- Japan
- Prior art keywords
- drug
- vaseline
- headache
- stomach
- intestines
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
【発明の詳細な説明】 本発明は人体の内表及に持いる薬に関するものである。[Detailed description of the invention] TECHNICAL FIELD The present invention relates to drugs for internal use in the human body.
内表及とは消化器系及び呼吸器系においての外側に出て
いないが外界物と直接せっすることのある人体組織をい
い消化器系では飲食物の通るところであり、呼吸器系で
は頭、肺その他である。従来の内服薬では胃を痛める等
の副作用があり問題として残っていたものをワセリンと
いっしょに服用することにより胃壁等を保■して副作用
を押える作用がある。またワセリンは人体に吸収されず
又消化作業の防案にもならないのである。従来の頭痛薬
は内服が多くて脳間の外界物よりの損傷に対して直接投
薬することがなかったものを鼻腔より吸引させて直接投
薬を得ようとするものであり。また口腔よりの毒物によ
る■への作用に対しては口腔内に塗付して特に上口腔部
に塗付することにより薬効を得ることが出来る。これら
の処方により精神病院への入院もす■ることなく、また
数的にも少なくなるであろう。Inner circulation refers to human body tissues that do not go outside in the digestive and respiratory systems but come into direct contact with external substances.In the digestive system, food and drink pass through, and in the respiratory system, it is the head, These include the lungs and other areas. Conventional oral medications have had side effects such as stomach pain, which remains a problem, but when taken together with petrolatum, it has the effect of protecting the stomach wall and suppressing side effects. Also, Vaseline is not absorbed by the human body and does not provide protection against digestion. Conventional headache medicines are often taken orally and are not directly administered to treat damage caused by external substances between the brain, but they are inhaled through the nasal cavity to provide direct medication. In addition, for the effects of poisonous substances from the oral cavity, medicinal effects can be obtained by applying it to the oral cavity, especially to the upper oral cavity. With these prescriptions, hospitalizations in psychiatric hospitals will be avoided and the number of hospitalizations will be reduced.
調剤として特許請求の範囲４を示したがこればかりでな
く種々の薬をワセリンとまぜることにより副作用の少な
い薬を作ることが出来るであろう。またこれらをダブル
に用いることにより人体には感じられないような浮遊物
癌等の毒性からくる心身症をしずめ、それからのがれる
ことが出来るであろう。Claim 4 is shown as a preparation, but by mixing various drugs with vaseline, it will be possible to create drugs with fewer side effects. Also, by using these drugs in combination, it will be possible to relieve and escape from psychosomatic illnesses caused by toxicity, such as floater cancer, which cannot be felt by the human body.
特許出願人 今野富■Patent applicant: Tomi Konno
Claims (1)
法 ２）ワセリンにｄｌ−カンフル、ｌ−アントール、ユー
カリ油、パイン油等を入れたものを胃腸薬として内服に
持いる方法 ３）ワセリンにｄｌ−カンフル、ｌ−メントール、ユー
カリ油、パイン油等を入れたものを鼻腔より吸引させて
又は口腔上部に塗付させて頭痛薬として持いる方法 ４）特許請求の範囲及び３の調剤としてｄｌ−カンフル
９．６％、ｌ−メントール １．３５％、ユーカリ油１．３０％、パイン油０．３６
％、白色ワセリン６８．５５％、黄色ワセリン１８．７
４％とする方法[Scope of Claims] 1) A method of having petrolatum as an agent or additive for a drug to be taken. 2) A method of taking petrolatum containing dl-camphor, l-anthol, eucalyptus oil, pine oil, etc. as a gastrointestinal medicine. 3) Method of holding Vaseline containing dl-camphor, l-menthol, eucalyptus oil, pine oil, etc. as a headache medicine by inhaling it through the nasal cavity or applying it to the upper part of the mouth 4) According to the patent claim Range and 3 formulations include dl-camphor 9.6%, l-menthol 1.35%, eucalyptus oil 1.30%, pine oil 0.36
%, white petrolatum 68.55%, yellow petrolatum 18.7
How to set it to 4%
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP11034082A JPS58225012A (en) | 1982-06-25 | 1982-06-25 | Composition of drug for stomach and intestines, and for headache, and its preparation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP11034082A JPS58225012A (en) | 1982-06-25 | 1982-06-25 | Composition of drug for stomach and intestines, and for headache, and its preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPS58225012A true JPS58225012A (en) | 1983-12-27 |
Family
ID=14533268
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP11034082A Pending JPS58225012A (en) | 1982-06-25 | 1982-06-25 | Composition of drug for stomach and intestines, and for headache, and its preparation |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS58225012A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001043736A1 (en) * | 1999-12-14 | 2001-06-21 | Teikoku Seiyaku Co., Ltd. | Drugs for relieving hemicrania |
-
1982
- 1982-06-25 JP JP11034082A patent/JPS58225012A/en active Pending
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001043736A1 (en) * | 1999-12-14 | 2001-06-21 | Teikoku Seiyaku Co., Ltd. | Drugs for relieving hemicrania |
| US7235257B1 (en) | 1999-12-14 | 2007-06-26 | Rohto Pharmaceutical Co., Ltd. | Drugs for relieving hemicrania comprising 1-menthol and essential oils |
| JP4575632B2 (en) * | 1999-12-14 | 2010-11-04 | 帝國製薬株式会社 | Drugs for migraine relief |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NL990012I1 (en) | Medicines containing salmeterol and fluticasone. | |
| DE69527842D1 (en) | LIQUID MEDICINAL PRODUCT CONTAINING ORAL ALENDRONATE | |
| CA2195065A1 (en) | Inhalation composition | |
| RU2008119454A (en) | MEDICINE FOR PROTECTION OF MOTOR NEURON IN PATIENTS WITH LATERAL AMYOTROPHIC SCLEROSIS | |
| JP2005533021A5 (en) | ||
| RU95101385A (en) | Products containing g-csf and tnf-binding protein | |
| KR970061244A (en) | Pharmaceutical composition for treating dementia | |
| CA2038744A1 (en) | Pharmaceutical composition containing slightly water-soluble drug | |
| GB2181646A (en) | Medicated chewing gum | |
| Van der Bijl et al. | Rectal ketamine and midazolam for premedication in pediatric dentistry | |
| Kojima et al. | Comparison of Sedative Effects of Medetomidine‐Midazolam,. Acepromazine‐Butorphanol and Midazolam‐Butorphanol in Dogs | |
| Berge | Nitrous oxide in dental surgery | |
| JPS58225012A (en) | Composition of drug for stomach and intestines, and for headache, and its preparation | |
| KR860003018A (en) | Medical treatment of non-viral diseases of human body using 1-β-D-ribofuranosyl-1,2,4-triazole-3-carboxamide | |
| US3156614A (en) | Medicinal compositions and method for relieving cough | |
| DE69531166D1 (en) | MEDICINAL PRODUCT TO RELEASE THE SIDE EFFECTS CAUSED BY IMMUNE SUPPRESSIVES | |
| RU2199336C1 (en) | Biologically active substance | |
| ATE91890T1 (en) | MANUFACTURE OF A DRUG AGAINST ARTHRITIS AND RHEUMATISM. | |
| RU94044812A (en) | Method of patient ataralgesia at stomatologic operations | |
| FINN et al. | Comparison of the effects of RO 5–6901, pentobarbital, and meperidine on the respiratory response to carbon dioxide | |
| Capiat | to ten grains daily, constitute remedy with distinguished practi | |
| JPS6360926A (en) | Cold remedy | |
| JPS62123111A (en) | Non-absorbable gastrointestinal drug supplied in from of gastric-soluble and gastric-resistant crude drug and curing two levels of digestive tract | |
| Glassington | Dental materia medica, pharmacology and therapeutics | |
| JPH0466529A (en) | Cytopathogenic inhibitor and organotoxic reliever |